Adia Nutrition, Inc. (ADIA)
D
Pipeline Grade
Financial Position (from SEC Filings)
$0.1M
Cash & Equivalents
$0.1M
Quarterly Burn Rate
7 mo
Est. Cash Runway
$14M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07304440 | Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study | PHASE2 | Recruiting | 100 |
| NCT07587047 | Adia Med of Winter Park LLC Lower Back Pain Research Study | PHASE1 | Recruiting | 100 |
| NCT07572890 | Adia Med of Winter Park LLC Chronic Kidney Disease Research Study | PHASE1 | Recruiting | 100 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.